The Enterprise Value as of November 2024 (TTM) for NLS Pharmaceutics AG (NLSP) is 11.84M

According to NLS Pharmaceutics AG’s latest financial reports and current stock price. The company's current Enterprise Value is 11.84M. This represents a change of -98.86% compared to the average of 1.03B of the last 4 quarters.

NLS Pharmaceutics AG (NLSP) Historical Enterprise Value (quarterly & annually)

How has NLSP Enterprise Value performed in the past?

The mean historical Enterprise Value of NLS Pharmaceutics AG over the last ten years is 1.02B. The current 11.84M Enterprise Value has changed 16.10% with respect to the historical average. Over the past ten years (40 quarters), NLSP's Enterprise Value was at its highest in in the June 2023 quarter at 1.68B. The Enterprise Value was at its lowest in in the March 2017 quarter at 0.

NLS Pharmaceutics AG (NLSP) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of NLS Pharmaceutics AG Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

NLS Pharmaceutics AG (NLSP) Average Enterprise Value

How has NLSP Enterprise Value performed in the past?

The current Enterprise Value of NLS Pharmaceutics AG (NLSP) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

NLS Pharmaceutics AG (NLSP) Enterprise Value vs. Peers

How is NLSP’s Enterprise Value compared to its peers?

NLS Pharmaceutics AG’s Enterprise Value is greater than NeuroBo Pharmaceuticals, Inc. (-5698320.00), greater than Indaptus Therapeutics, Inc. (4.86M), greater than Pasithea Therapeutics Corp. (-4151453.00), greater than Quoin Pharmaceuticals, Ltd. (3.26M), greater than Lixte Biotechnology Holdings, Inc. (1.61M), less than Anebulo Pharmaceuticals, Inc. (45.92M), less than NervGen Pharma Corp. (146.45M), less than Acrivon Therapeutics, Inc. Common Stock (200.42M), greater than Protagenic Therapeutics, Inc. (1.79M), less than Miromatrix Medical Inc. (90.06M), less than Rezolute, Inc. (235.52M), less than HCW Biologics Inc. (25.13M), less than Eliem Therapeutics, Inc. (119.64M), less than Molecular Partners AG (57.62M), less than Assembly Biosciences, Inc. (85.72M), greater than Neoleukin Therapeutics, Inc. (-6333315.00), less than Instil Bio, Inc. (261.11M), less than CytomX Therapeutics, Inc. (46.42M), greater than Achilles Therapeutics plc (-48532901.00),

Build a custom stock screener for NLS Pharmaceutics AG (NLSP) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like NLS Pharmaceutics AG using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

NLS Pharmaceutics AG (NLSP) and other stocks custom spreadsheet templates

The easiest way to analyze a company like NLS Pharmaceutics AG or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.